Ionis Pharmaceuticals Inc (IONS)
37.60
+1.05
(+2.87%)
USD |
NASDAQ |
May 31, 16:00
37.58
-0.02
(-0.04%)
After-Hours: 20:00
Ionis Pharmaceuticals Total Return Level: 37.60 for May 31, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 31, 2024 | 37.60 |
May 30, 2024 | 36.55 |
May 29, 2024 | 36.45 |
May 28, 2024 | 37.64 |
May 24, 2024 | 37.28 |
May 23, 2024 | 38.00 |
May 22, 2024 | 38.00 |
May 21, 2024 | 37.37 |
May 20, 2024 | 38.72 |
May 17, 2024 | 37.31 |
May 16, 2024 | 37.62 |
May 15, 2024 | 39.21 |
May 14, 2024 | 38.27 |
May 13, 2024 | 38.80 |
May 10, 2024 | 39.08 |
May 09, 2024 | 39.47 |
May 08, 2024 | 40.16 |
May 07, 2024 | 40.93 |
May 06, 2024 | 42.28 |
May 03, 2024 | 41.97 |
May 02, 2024 | 43.09 |
May 01, 2024 | 43.01 |
April 30, 2024 | 41.26 |
April 29, 2024 | 41.99 |
April 26, 2024 | 41.59 |
Date | Value |
---|---|
April 25, 2024 | 41.84 |
April 24, 2024 | 42.45 |
April 23, 2024 | 41.84 |
April 22, 2024 | 41.07 |
April 19, 2024 | 40.68 |
April 18, 2024 | 40.81 |
April 17, 2024 | 40.91 |
April 16, 2024 | 41.54 |
April 15, 2024 | 41.55 |
April 12, 2024 | 41.74 |
April 11, 2024 | 42.50 |
April 10, 2024 | 42.94 |
April 09, 2024 | 42.83 |
April 08, 2024 | 42.24 |
April 05, 2024 | 43.22 |
April 04, 2024 | 42.83 |
April 03, 2024 | 43.78 |
April 02, 2024 | 43.00 |
April 01, 2024 | 43.94 |
March 28, 2024 | 43.35 |
March 27, 2024 | 44.66 |
March 26, 2024 | 44.11 |
March 25, 2024 | 43.91 |
March 22, 2024 | 42.72 |
March 21, 2024 | 42.75 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
25.61
Minimum
Dec 01 2021
72.15
Maximum
Aug 21 2019
46.07
Average
43.59
Median
Mar 23 2021
Total Return Level Benchmarks
Biogen Inc | 224.93 |
Viking Therapeutics Inc | 62.30 |
Madrigal Pharmaceuticals Inc | 236.29 |
Akero Therapeutics Inc | 18.82 |
89bio Inc | 7.90 |